newsfilter
← Latest News
PR Newswire·

Liminal Biosciences Confirms Receipt of Unsolicited Non-Binding Transaction Proposal

LAVAL, QC and CAMBRIDGE, England, April 5, 2023 /CNW/ - Liminal BioSciences Inc. (NASDAQ:LMNL) ("Liminal BioSciences" or the "Company"), confirms that following close of markets on April 4, 2023, the